CARLSBAD, CALIFORNIA–(Marketwired – Sept. 17, 2014) – Aurora Spine Corporation (TSX VENTURE:ASG) is excited to announce the launch of the first wave of next generation lumbar Interbody Cages. The ECHO™ MIS Interbody System (PLIF) and ECHO XL™ MIS Interbody System (OLIF) feature Aurora’s new TiNano™ titanium spray coating technology. TiNano coated PEEK-OPTIMA cages will allow for the possibility of bone ongrowth due to its porous structure.

“I was privileged to be the first neurosurgeon in the United States to use Aurora’s TiNano spinal fusion cages,” said Luis Duarte, M.D. at Shannon Medical Center in San Angelo, TX. “I was impressed with the technology because I believe these spinal cages increase the chance for stronger bone-implant interface, which could lead to less complications and faster healing. Traditional spinal cages are inert, that is biologically inactive. With Aurora’s new cutting edge technology I expect my patients to heal faster and obtain a more robust spinal fusion.”

The TiNano surface is created by thermal spray technology of Titanium particles to support osseointegration. TiNano coated cages provide several advantages including: additional roughness and porosity, increased possibility of bone ongrowth and enhanced radiographic visibility. TiNano will be available on all Aurora interbody cages, including Cervical, PLIF, OLIF, TLIF, ALIF and LLIF.

“Aurora is changing spine surgery, and we are thrilled to launch a comprehensive line of titanium coated PEEK implants,” said Trent J. Northcutt, Aurora’s President and Chief Executive Officer. “The new TiNano interbody portfolio maintains our position at the forefront, introducing innovative minimally invasive spinal implant technologies. We designed the TiNano coated interbody cages to improve spine patient outcomes, drive continued surgeon interest, and bolster our relevance as a key innovator in spine. We expect that the new TiNano interbody products will continue to stimulate increased use of our innovative ZIP™ MIS Interspinous Fusion Implants.”

About Aurora Spine

Aurora Spine is an early stage company focused on bringing new solutions to the spinal implant market through a series of innovative, minimally invasive, regenerative spinal implant technologies.

Forward-Looking Statements

This news release contains forward-looking information that involves substantial known and unknown risks and uncertainties, most of which are beyond the control of Aurora Spine, including, without limitation, those listed under “Risk Factors” and “Cautionary Statement Regarding Forward-Looking Information” in Aurora Spine’s final prospectus (collectively, “forward-looking information”). Forward-looking information in this news release includes information concerning the proposed use and success of the company’s products in surgical procedures. Aurora Spine cautions investors of Aurora Spine’s securities about important factors that could cause Aurora Spine’s actual results to differ materially from those projected in any forward-looking statements included in this news release. Any statements that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and may be forward-looking and may involve estimates, assumptions and uncertainties which could cause actual results or outcomes to differ unilaterally from those expressed in such forward-looking statements. No assurance can be given that the expectations set out herein will prove to be correct and, accordingly, prospective investors should not place undue reliance on these forward looking statements. These statements speak only as of the date of this press release and Aurora Spine does not assume any obligation to update or revise them to reflect new events or circumstances.